| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $4.2M | 0.01% | 669.42K | −23% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a LFVN trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 14, 2026 | Lewis Darwin KDirector | Purchase at price 6.22 per share. | 976 | $6.07K |
| Sep 13, 2026 | Cunningham KristenOfficer | Sale at price 6.18 - 6.41 per share. | 9K | $55.65K |
| Aug 5, 2026 | Moorehead TerrenceChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 308.6K | — |
| Jun 14, 2026 | Lewis Darwin KDirector | Purchase at price 6.61 per share. | 705 | $4.66K |
| Jun 2, 2026 | Beindorff Michael A.Director | Sale at price 8.55 per share. | 10K | $85.46K |
| Mar 15, 2026 | Lewis Darwin KDirector | Purchase at price 5.23 per share. | 1.1K | $5.52K |
| Mar 1, 2026 | Judd Dayton RDirector | Purchase at price 4.53 - 4.63 per share. | 33.2K | $152.42K |
| Feb 8, 2026 | Lewis Darwin KDirector | Purchase at price 5.22 per share. | 4K | $20.65K |
| Dec 14, 2025 | Lewis Darwin KDirector | Purchase at price 6.54 per share. | 805 | $5.26K |
| Nov 24, 2025 | Beindorff Michael A.Director | Stock Gift at price 0.00 per share. | 7.8K | — |
| Nov 18, 2025 | Beindorff Michael A.Director | Sale at price 6.42 per share. | 12.6K | $80.93K |
| Nov 6, 2025 | Beindorff Michael A.Director | Sale at price 6.92 - 7.33 per share. | 36K | $249.58K |
| Nov 5, 2025 | Lewis Darwin KDirector | Stock Award(Grant) at price 7.76 per share. | 13.5K | $105.00K |
| Nov 5, 2025 | Latham CynthiaDirector | Stock Award(Grant) at price 7.76 per share. | 13.5K | $105.00K |
| Nov 5, 2025 | Anbalagan RajendranDirector | Stock Award(Grant) at price 7.76 per share. | 13.5K | $105.00K |
| Nov 5, 2025 | Beindorff Michael A.Director | Stock Award(Grant) at price 7.76 per share. | 13.5K | $105.00K |
| Nov 5, 2025 | Greer Raymond BDirector | Stock Award(Grant) at price 7.76 per share. | 13.5K | $105.00K |
| Nov 5, 2025 | Judd Dayton RDirector | Stock Award(Grant) at price 7.76 per share. | 13.5K | $105.00K |
| Sep 15, 2025 | Lewis Darwin KDirector | Purchase at price 10.85 per share. | 450 | $4.88K |
| Sep 8, 2025 | Beindorff Michael A.Director | Sale at price 11.35 - 11.44 per share. | 4.3K | $49.46K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -14.0 | -12.3 | -7.1 | 16.9 | 55.8 | -20.7 | 3.0 | -1.6 | -0.5 | -4.4 | −2.3% | ||
| 2025 | 20.7 | -18.9 | -15.1 | -15.2 | 5.5 | 0.2 | -4.1 | 4.4 | -25.7 | -15.8 | -16.1 | -10.3 | −64.9% |
| 2024 | -11.5 | 28.4 | -11.3 | 0.8 | 24.8 | -15.6 | 27.4 | -2.7 | 51.8 | 1.2 | 19.6 | 20.0 | +192.2% |
| 2023 | 7.5 | -3.0 | -7.5 | -8.1 | 41.2 | -6.7 | 16.3 | 46.2 | -12.8 | 16.3 | -15.9 | -4.9 | +61.3% |
| 2022 | 1.7 | -13.2 | -14.7 | -18.1 | 5.4 | 5.8 | -2.3 | -6.4 | -5.8 | 7.5 | -7.2 | -0.5 | −41.1% |
| 2021 | -4.1 | -2.1 | 6.9 | -13.0 | -2.0 | -7.8 | 10.5 | -4.3 | -12.9 | 1.2 | -6.1 | -1.7 | −32.2% |
| 2020 | 4.9 | -27.3 | -13.5 | 50.5 | -1.2 | -11.7 | -5.0 | 17.0 | -19.6 | -8.5 | -3.8 | -12.3 | −40.3% |
| 2019 | 12.6 | -1.9 | -1.9 | -20.4 | -1.4 | 15.7 | -10.6 | 4.8 | 12.7 | -1.0 | 11.1 | 3.6 | +18.3% |
| 2018 | -6.7 | -10.6 | -9.1 | 5.0 | 26.4 | 33.0 | 51.6 | 30.0 | -12.5 | 0.2 | 21.9 | -1.7 | +177.1% |
| 2017 | -11.4 | -23.3 | -3.1 | -7.6 | -19.6 | 8.5 | -12.2 | 9.5 | 1.4 | 31.5 | -4.3 | -10.4 | −41.6% |
| 2016 | -12.1 | 19.4 | -8.9 | -0.8 | 38.2 | 9.0 | 2.9 | -12.4 | -22.8 | -13.3 | -1.3 | 0.7 | −14.4% |
| 2015 | -2.3 | -22.8 | -19.4 | 0.0 | -15.4 | -20.7 | 10.2 | 45.5 | -4.7 | 36.2 | 9.6 | 12.5 | +4.6% |
| 2014 | -25.5 | 8.1 | -1.5 | 5.3 | -4.3 | 9.1 | -9.7 | -2.3 | -10.2 | 18.4 | 0.0 | -3.7 | −21.2% |
| 2013 | 21.0 | -4.5 | -7.1 | -3.0 | -3.1 | 5.0 | 12.5 | -7.7 | -1.2 | -8.0 | -12.3 | -14.1 | −24.7% |
| 2012 | -1.4 | 41.8 | 88.0 | -1.6 | -16.8 | -8.1 | 13.1 | -6.9 | 15.1 | -7.0 | -20.4 | -13.8 | +53.1% |
| 2011 | 61.5 | 11.1 | 1.4 | 88.7 | 16.4 | -3.8 | -6.0 | 4.3 | 2.0 | -4.0 | 0.7 | -1.4 | +266.7% |
| 2010 | 40.0 | 2.9 | 8.3 | 51.3 | 15.3 | -25.0 | 17.5 | -1.5 | -15.3 | -14.0 | -11.6 | 2.6 | +56.0% |
| 2009 | 0.0 | 25.0 | 210.0 | 3.2 | -12.5 | -4.3 | -19.4 | -1.9 | -27.4 | -29.9 | -7.4 | 0.0 | +25.0% |
| 2008 | 85.0 | -13.5 | -26.6 | 57.4 | -24.3 | -10.7 | -20.0 | -25.0 | 33.3 | -35.0 | -23.1 | 100.0 | 0.0% |
| 2007 | 18.2 | -42.3 | 13.3 | -44.1 | 0.0 | 26.3 | 25.0 | -26.7 | 0.0 | -9.1 | 5.0 | -4.8 | −54.5% |
Buy / hold / sell counts
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; P84 System, a product activator consisting of PhytoPower 1 and PhytoPower 2 that contains probiotics, prebiotics, postbiotics, digestive enzymes, and superfood blends designed to support gut health; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.